Page last updated: 2024-10-18

dihydroxyacetone phosphate and Basal Ganglia Diseases

dihydroxyacetone phosphate has been researched along with Basal Ganglia Diseases in 1 studies

Dihydroxyacetone Phosphate: An important intermediate in lipid biosynthesis and in glycolysis.
dihydroxyacetone phosphate : A member of the class of glycerone phosphates that consists of glycerone bearing a single phospho substituent.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Orosz, F1
Wágner, G1
Liliom, K1
Kovács, J1
Baróti, K1
Horányi, M1
Farkas, T1
Hollán, S1
Ovádi, J1

Other Studies

1 other study available for dihydroxyacetone phosphate and Basal Ganglia Diseases

ArticleYear
Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Feb-01, Volume: 97, Issue:3

    Topics: Anemia, Hemolytic, Congenital; Animals; Basal Ganglia Diseases; Binding, Competitive; Biological Tra

2000